Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (271-280 of 403) with videos related to

Pageof 41
Sort By:
The Journal of Infection|May 2, 2021
Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, EnglandAmoolya Vusirikala, Heather Whitaker, Samuel Jones, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
Archives of Pathology & Laboratory Medicine|September 26, 2002
Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreakAndrew J Pollard, Gary Probe, Colleen Trombley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Vaccine|May 28, 2014
The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccinesOlubukola T Idoko, Seline N Okolo, Brian Plikaytis, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2014
Neisseria adhesin A variation and revised nomenclature schemeStefania Bambini, Matteo De Chiara, Alessandro Muzzi, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
Vaccine|June 13, 2006
From genomics to surveillance, prevention and control: new challenges for the African meningitis beltJean-Michel Alonso, Eric Bertherat, William Perea, et al.
Human Vaccines & Immunotherapeutics|November 27, 2019
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269Maria Stella, Maria Giuliani, Alessia Biolchi, et al.
The Journal of Infectious Diseases|March 3, 2007
Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina FasoHelen Findlow, Ulrich Vogel, Judith E Mueller, et al.
Pageof 41

Showing results (271-280 of 403) with videos related to

Sort By:
Pageof 41
The Journal of Infection|May 2, 2021
Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, EnglandAmoolya Vusirikala, Heather Whitaker, Samuel Jones, et al.
Msphere|August 24, 2018
Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <i>Neisseria meningitidis</i> Isolated from 2009 to 2013 in the Republic of IrelandRobert M Mulhall, Desiree Bennett, Robert Cunney, et al.
Archives of Pathology & Laboratory Medicine|September 26, 2002
Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreakAndrew J Pollard, Gary Probe, Colleen Trombley, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2010
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancyJamie Findlow, Ray Borrow, Matthew D Snape, et al.
Vaccine|May 28, 2014
The impact of pre-existing antibody on subsequent immune responses to meningococcal A-containing vaccinesOlubukola T Idoko, Seline N Okolo, Brian Plikaytis, et al.
Clinical and Vaccine Immunology : CVI|May 9, 2014
Neisseria adhesin A variation and revised nomenclature schemeStefania Bambini, Matteo De Chiara, Alessandro Muzzi, et al.
The Lancet. Public Health|December 19, 2017
Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort studyMirjam J Knol, Susan J M Hahné, Jay Lucidarme, et al.
Vaccine|June 13, 2006
From genomics to surveillance, prevention and control: new challenges for the African meningitis beltJean-Michel Alonso, Eric Bertherat, William Perea, et al.
Human Vaccines & Immunotherapeutics|November 27, 2019
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269Maria Stella, Maria Giuliani, Alessia Biolchi, et al.
The Journal of Infectious Diseases|March 3, 2007
Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina FasoHelen Findlow, Ulrich Vogel, Judith E Mueller, et al.
Pageof 41